NICE was unable to develop medical technologies guidance on the Assurance Nasal Alar SpO2 Sensor because no evidence submission was received from the company.
- Status:
- Discontinued
- Decision:
- Prioritised
- Process:
- MTG
- ID number:
- 310
Email enquiries
If you have any queries please email medtech@nice.org.uk
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 27 March 2017 | Discontinued. NICE was unable to develop medical technologies guidance on the Assurance Nasal Alar SpO2 Sensor because no evidence submission was received from the company. |
For further information on our processes and methods, please see our CHTE processes and methods manual